Citation: | CHEN Yunhao, LI Liubing, ZHOU Zhenhai. Characteristics of bone marrow megakaryocytes in patients with idiopathic thrombocytopenic purpura complicated with positive antinuclear antibody[J]. Journal of Clinical Medicine in Practice, 2024, 28(24): 48-52. DOI: 10.7619/jcmp.20244956 |
To investigate the characteristics of bone marrow megakaryocytes in patients with idiopathic thrombocytopenic purpura (ITP) complicated with positive for antinuclear antibody (ANA) but cannot be diagnosed as rheumatic immune diseases.
Newly diagnosed ITP patients in the First Hospital Affiliated to Sun Yat-sen University were retrospectively selected and divided into ITP1 group (ITP patients with positive ANA) and ITP2 group (ITP patients with negative rheumatic indicators). Degree of thrombocytopenia, the total number of bone marrow megakaryocytes, and the ratios of various types of megakaryocytes at the initial diagnosis were compared between the two groups.
A total of 42 newly diagnosed ITP patients were included, with 20 cases in the ITP1 group and 22 cases in the ITP2 group. There were no significant differences in general information such as gender and age between the two groups (P>0.05). The platelet (PLT) count was (7.55±0.96)×109/L in the ITP1 group, which was lower than (10.23±1.21)×109/L in the ITP2 group, but there was no significant between-group difference (t=1.697, P=0.097). Compared with the ITP2 group, the total number of megakaryocytes in the ITP1 group was significantly decreased (t=3.071, P < 0.01), and the ratio of granular megakaryocytes was significantly increased while the ratio of naked nuclear megakaryocytes was significantly decreased (P < 0.05); there were no significant differences in the ratios of immature and platelet-producing megakaryocytes between the two groups (P>0.05).
Patients with ITP and positive ANA have a tendency of decreased PLT, and a more significant maturation disorder of bone marrow megakaryocytes, with a lower degree of megakaryocyte proliferation compared to patients without positive ANA. ANA may exacerbate the severity of ITP by aggravating the developmental disorder of bone marrow megakaryocytes.
[1] |
中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志, 2020, 41(8): 617-623.
|
[2] |
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185.
|
[3] |
PAMUK O N, ALI S M, HASNI S. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis[J]. Autoimmunity reviews, 2023, 22(4): 103297-103297. . doi: 10.1016/j.autrev.2023.103297
|
[4] |
ANDRADE L E C, DAMOISEAUX J, VERGANI D, et al. Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases[J]. J Transl Autoimmun, 2022, 5: 100145. doi: 10.1016/j.jtauto.2022.100145
|
[5] |
BRIK-SIMON D, EFROS O, LEVINSKY Y, et al. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia[J]. Pediatr Blood Cancer, 2024, 71(5): e30911. doi: 10.1002/pbc.30911
|
[6] |
LIU J, ZHANG Y L, LI Z, et al. The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia[J]. Br J Haematol, 2023, 202(2): 412-421. doi: 10.1111/bjh.18732
|
[7] |
LIU Y, CHEN S J, YANG G M, et al. ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases[J]. Lupus Sci Med, 2021, 8(1): e000523. doi: 10.1136/lupus-2021-000523
|
[8] |
OSTROV B E. Reliability and reproducibility of antinuclear antibody testing in pediatric rheumatology practice[J]. Front Med, 2022, 9: 1071115.
|
[9] |
秦伟, 韩红满, 左立辉, 等. 血小板减少症患者抗核抗体与抗核抗体谱的表达与其年龄和性别的关系[J]. 海南医学, 2019, 30(7): 836-838.
|
[10] |
李文君, 陈文静, 邵群, 等. 多发性骨髓瘤患者异常浆细胞CD27表达和免疫表型与肿瘤预后的关系[J]. 实用临床医药杂志, 2024, 28(15): 110-114. doi: 10.7619/jcmp.20240902
|
[11] |
孙博洋, 杨仁池. 免疫性血小板减少性紫癜的发病机制[J]. 国际输血及血液学杂志, 2017, 40(3): 204-208.
|
[12] |
刘新光, 侯明. 成人原发免疫性血小板减少症: 2019版美国血液学会指南与国际共识报告更新解读[J]. 中华血液学杂志, 2020, 41(6): 441-445.
|
[13] |
许建红, 陈元锋, 竺青, 等. 长链非编码RNA TMEVPG1在原发性免疫性血小板减少症患者预后评估中的价值[J]. 实用临床医药杂志, 2023, 27(3): 16-20. doi: 10.7619/jcmp.20221880
|